
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.
The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.
NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreAll marketing authorization holders of medicine are hereby informed that as informed earlier, the price determination process for import licences will commence for all import licences that expire and are renewed after 1st November 2025.
To ensure timely processing and avoid delays,all applicants are advised to submit their import licence applications at least twelve (12) weeks in advance to the National Medicines Regulatory Authority(NMRA).
Applicants are required to:
Submission of Import Licence Applications
Email Submission of Price Details
Applicants need to complete the attached Excel format and the format for Submission of price details for Dossiers (New/ RR/ Renewal/Variation) & Import Licenses (F-PD-001 Effective date 04.09.2025/V1.0/RevNo 0), and email to: pricing@nmra.gov.lk at the time of submitting the import licence application.
Subject of the email:IL[Dossier number] [generic name of the product]
3. Submission of Price Details for Dossiers (New/ RR/ Renewal/ Variation) & Import Licenses
(Document Reference: F-PD-001 | Effective Date: 04.09.2025 | Version: 1.0 | Rev. No: 0)
The National Medicines Regulatory Authority (NMRA) of Sri Lanka has implemented anew security feature to enhance the integrity and authenticity of all certificates and licenses issued by NMRA.
Implementation Timeline
All documents issued on or after the respective dates will include the official NMRA hologram sticker.
Benefits of the Hologram Sticker
Required Actions for Stakeholders
All importers, manufacturers, and license holders are advised to:
Contact for Assistance
For further information or clarification, please reach out to:
Licensing Division
National Medicines Regulatory Authority
And
Pharmacy Division
National Medicines Regulatory Authority
The National Medicines Regulatory Authority (NMRA) wishes to inform the public of the updated list of licensed retail pharmacies in Sri Lanka. This list includes all pharmacies that have been granted a valid license to operate as of September 2025.
List of Licensed Retail Pharmacies in Sri Lanka
Notice to All Authorized Local Agents,
This is to kindly inform all authorized local agents that the USD rate considered for the month of September 2025 for processing price details of medicines / medical devices is 304.57
Please ensure that all price submission for MRP approvals are prepared accordingly.
For the information of all marketing authorization holders.
The Pricing Division will hold a Public Day for local agents to discuss matters related to pending applications on Wednesday,27th August 2025 at 10.00 A.M. To participate please schedule an appointment by entering your details in the book available with the Security Officer on the 2nd Floor. Please ignore the previous notice and sorry for any inconvenience if occurred.